Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Tesamorelin Acetate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Theratechnologies Resumes Distribution of EGRIFTA SV®
    Theratechnologies Resumes Distribution of EGRIFTA SV®

    13 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/14/3026381/0/en/Theratechnologies-Resumes-Distribution-of-EGRIFTA-SV.html

    GLOBENEWSWIRE
    13 Feb 2025
    Share Share
    Theratechnologies Provides Update on EGRIFTA SV® Supply
    Theratechnologies Provides Update on EGRIFTA SV® Supply

    09 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/09/3007379/0/en/Theratechnologies-Provides-Update-on-EGRIFTA-SV-Supply.html

    GLOBENEWSWIRE
    09 Jan 2025
    Share Share
    Theratechnologies Receives March 2025 PDUFA Date
    Theratechnologies Receives March 2025 PDUFA Date

    10 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/12/10/2994926/0/en/Theratechnologies-Receives-March-2025-PDUFA-Goal-Date-for-Updated-Tesamorelin-F8-Formulation-sBLA.html

    GLOBENEWSWIRE
    10 Dec 2024
    Share Share
    Theratechnologies Submit Updated Tesamorelin F8 sBLA for FDA Review
    Theratechnologies Submit Updated Tesamorelin F8 sBLA for FDA Review

    26 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/26/2987389/0/en/Theratechnologies-Submits-Updated-Tesamorelin-F8-Formulation-sBLA-for-FDA-Review.html

    GLOBENEWSWIRE
    26 Nov 2024
    Share Share
    Theratechnologies Warns Of Egrifta Supply Disruption After Plant Shutdown
    Theratechnologies Warns Of Egrifta Supply Disruption After Plant Shutdown

    18 Sep 2024

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/theratechnologies-warns-hiv-med-disruption-after-third-party-plant-shutdown

    FIERCE PHARMA
    18 Sep 2024
    Share Share
    Theratechnologies Announces Risk of EGRIFTA SV® Supply Disruption
    Theratechnologies Announces Risk of EGRIFTA SV® Supply Disruption

    17 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/17/2947862/0/en/Theratechnologies-Announces-a-Risk-of-a-Temporary-Supply-Disruption-for-EGRIFTA-SV-in-Early-2025.html

    GLOBENEWSWIRE
    17 Sep 2024
    Share Share